Go to deals
Healthcare

MediCa group has been acquired by Repharm

CGP Management has sold MediCa group, the largest private provider of healthcare services in Lithuania, to Repharm.

MediCa group is present in all levels of the healthcare system with primary, specialist and hospital care being the core business areas. Primary and selected specialist care services are provided in 30 clinics across Lithuania under the brand name MediCa. Kardiolitos Klinikos, which is the only private hospital in Lithuania, has three specialist centers, located in Vilnius, Kaunas, and Šiauliai, providing inpatient and outpatient healthcare services and is a nationally acknowledged center of excellence for cardiology services.

Repharm is a Latvian group of companies providing a wide range of healthcare services, from healthy lifestyle counseling to diagnosis and treatment. The group includes Sentor Farm Aptiekas (pharmacies operating under the Mēness Aptieka brand), Veselības Centru Apvienība (a chain of private clinics), Centrālā Laboratorija (a medical laboratory), Rīgas farmaceitiskā fabrika (manufacturer of galenic preparations, soft pharmaceuticals and herbal drugs and teas) and Recipe Plus (wholesale trader of pharmaceutical and healthcare products).

Oaklins’ team in Lithuania advised CGP Management on the sale of MediCa group to Repharm.

Service
M&A sell-side
Parties

Talk to the deal team

 Natalja  Titova

Natalja Titova

Associate Partner

Vilnius, Lithuania
Oaklins Baltics
 Mindaugas  Matulaitis

Mindaugas Matulaitis

Associate Partner

Vilnius, Lithuania
Oaklins Baltics
 Ieva Kamilė Paleckytė

Ieva Kamilė Paleckytė

Analyst

Vilnius, Lithuania
Oaklins Baltics
 Agnė  Purlytė

Agnė Purlytė

Analyst

Vilnius, Lithuania
Oaklins Baltics

Related deals

Global Media Santé has been acquired by SFP Expansion
Private Equity | Healthcare | TMT

Global Media Santé has been acquired by SFP Expansion

Global Media Santé’s CEO, Alain Trébucq, and Apax Partners have sold the company to SFP Expansion Group.

Learn more
Synairgen has successfully raised US$114 million to support phase III trial of COVID candidate
Healthcare

Synairgen has successfully raised US$114 million to support phase III trial of COVID candidate

Synairgen plc has completed its oversubscribed equity fundraising to raise US$114 million to fund a phase III trial for 900 patients for the effects of its SNG001 drug on patients with COVID-19. In addition, the raise will be used to scale up manufacturing and device activities.

Learn more
Westminster Homecare has been acquired by Care at Home
Healthcare

Westminster Homecare has been acquired by Care at Home

The private shareholders of Westminster Homecare Ltd. have sold the company to Care at Home Services (South East) Ltd.

Learn more